Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza

Expert Opinion on Drug Discovery
Alexandre MonodAnny Slama-Schwok

Abstract

Influenza viruses are a threat to human health. There are presently only two methods for treating influenza: vaccines, which require yearly updates, and two classes of antivirals that suffer with the problem of resistance by current human influenza viruses; this is especially the case with amantadine and rimantadine. Consequently, there is an urgent need for the development of new antivirals with new mechanisms of action. In this review, the authors focus on viral protein domains, their associated activity and their inhibition by small molecules defined by a structure-based design with a special emphasis on the ribonucleoprotein complex and its inhibitors. Several new classes of antiviral candidates targeting viral replication through individual domains of the polymerase and the nucleoprotein (NP) have been developed through structure-based design. To date, the antivirals targeting neuraminidase are by far the most developed and potent. Antiviral candidates targeting the NP and polymerase domains are in the pipeline but their pharmacokinetics needs further studies. The recently published structures of the polymerase expand the possibilities for development of new antivirals. Combination therapies targeting conserved viral targe...Continue Reading

References

Mar 22, 2002·The Journal of General Virology·Agustín Portela, Paul Digard
Jun 20, 2002·Journal of Virology·George G Brownlee, Jane L Sharps
May 12, 2007·Journal of Virology·Alexander GhanemMartin Schwemmle
Feb 1, 2008·Nature·Jason R Schnell, James J Chou
May 6, 2008·Nature Structural & Molecular Biology·Delphine GuilligayStephen Cusack
Jul 8, 2008·Antiviral Research·Donald F SmeeLarisa V Gubareva
Jul 11, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andy Ka-Leung NgPang-Chui Shaw
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rupert J RussellJohn J Skehel
Jun 27, 2009·PLoS Pathogens·Rocío ColomaJaime Martín-Benito
Apr 13, 2010·Nature Structural & Molecular Biology·Kalyan DasEddy Arnold
Jun 1, 2010·Nature Biotechnology·Richard Y KaoKwok-Yung Yuen
Nov 18, 2010·Nature Communications·Santosh RudrawarMark von Itzstein
Dec 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Regina CencicJerry Pelletier
Apr 7, 2011·Journal of Medicinal Chemistry·María D DuqueSantiago Vázquez
Apr 12, 2011·Bioorganic & Medicinal Chemistry Letters·Lei YouJon D Robertus
Aug 10, 2011·Current Opinion in Microbiology·Rob W H RuigrokDan Kolakofsky
Sep 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Samuel W GerritzMark Krystal
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yu-Fang ShenMing-Daw Tsai
Dec 14, 2011·Biochimie·B TarusA Slama-Schwok
Dec 27, 2011·Trends in Pharmacological Sciences·Konstantin H MüllerDenis E Kainov
Apr 5, 2012·Proceedings of the National Academy of Sciences of the United States of America·Giulia MuratoreArianna Loregian
Apr 13, 2012·Journal of Virology·Andy Ka-Leung NgPang-Chui Shaw
May 23, 2012·Journal of Medicinal Chemistry·Kalyan Das

❮ Previous
Next ❯

Citations

Jun 14, 2016·Journal of Medicinal Chemistry·Cy V CredilleSeth M Cohen
Jul 12, 2016·Nature Reviews. Microbiology·Aartjan J W Te Velthuis, Ervin Fodor
Dec 6, 2016·Expert Opinion on Investigational Drugs·Li-Yan ZengShuwen Liu
Aug 31, 2016·Scientific Reports·Philip D MosierUmesh R Desai
May 24, 2017·European Journal of Pharmacology·Simonides I van de WakkerRonald S Oosting
Feb 28, 2016·Virologica Sinica·Lanlan LiuJiahai Lu
Sep 27, 2018·Frontiers in Immunology·Sophia Davidson
Nov 4, 2020·Journal of Biomolecular Structure & Dynamics·Shahzaib AhamadVijay Kumar
Feb 11, 2021·Dalton Transactions : an International Journal of Inorganic Chemistry·Johannes KargesSeth M Cohen
Jul 22, 2018·Journal of Medicinal Chemistry·Sébastien DillyAnny Slama-Schwok
Sep 20, 2019·Journal of Medicinal Chemistry·Cy V CredilleSeth M Cohen
Sep 8, 2018·Chemical Reviews·Allie Y ChenSeth M Cohen
Oct 24, 2018·Journal of Medicinal Chemistry·Cy V CredilleSeth M Cohen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.